ALB and neoplasm: We used hepatocyte-specific deletion of PLAGL2 in mice (PLAGL2f/f Alb-cre) to validate whether knocking down PLAGL2 could inhibit epinephrine-induced tumorigenesis and tumor progression in vivo.